Detalhe da pesquisa
1.
Steady-state versus chemotherapy-based hematopoietic cell mobilization after anti-CD38-based induction therapy in newly diagnosed multiple myeloma.
Transfusion;
63(11): 2131-2139, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37850414
2.
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Ann Hematol;
102(3): 547-561, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36695874
3.
Analysis of stem cell collections in adult patients with Ewing sarcoma.
Transfusion;
62(8): 1612-1618, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35801531
4.
Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma.
Clin Lymphoma Myeloma Leuk;
2024 May 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38821728
5.
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.
Leukemia;
38(2): 372-382, 2024 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38184754
6.
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.
Nat Cancer;
2024 Apr 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38641734
7.
Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077.
Br J Haematol;
162(2): 202-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23692564
8.
Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study.
J Cancer Res Clin Oncol;
149(7): 3739-3752, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35987926
9.
Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report.
Front Oncol;
11: 798757, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35117998
10.
Spontaneous remission of acute myeloid leukemia relapse after hematopoietic cell transplantation in a high-risk patient with 11q23/MLL abnormality.
Acta Haematol;
119(2): 111-4, 2008.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18367831
11.
[Epigastric pain in "gastric tumors" : The hummingbird among the differential diagnoses]. / Epigastrische Schmerzen beim "Magentumor" : Der Kolibri unter den Differenzialdiagnosen.
Chirurg;
93(4): 395-398, 2022 04.
Artigo
em Alemão
| MEDLINE
| ID: mdl-34665283
12.
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).
J Cancer Res Clin Oncol;
143(12): 2545-2553, 2017 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28828689
13.
Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV).
J Cancer Res Clin Oncol;
143(10): 2049-2058, 2017 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28534173
14.
Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.
J Cancer Res Clin Oncol;
141(11): 2013-22, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25976868
15.
Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia.
Leuk Lymphoma;
55(6): 1274-80, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23964650
16.
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.
J Cancer Res Clin Oncol;
140(11): 1947-56, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24942335
17.
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.
J Cancer Res Clin Oncol;
139(3): 499-508, 2013 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23184429
18.
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.
J Cancer Res Clin Oncol;
139(11): 1937-46, 2013 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24046251